MedPath

Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria

Phase 1
Completed
Conditions
Incomplete Abortion
Interventions
Procedure: surgery Manual vacuum aspiration (MVA)
Registration Number
NCT01539408
Lead Sponsor
Gynuity Health Projects
Brief Summary

Women diagnosed with incomplete abortion in this health facility will be randomized to receive one of the following regimens: 400 mcg sublingual misoprostol in one dose or standard surgical treatment (MVA). The investigators hypothesize that treatment of incomplete abortion with misoprostol using 400 mcg administered sublingually will be as effective as surgical evacuation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • no contraindications to misoprostol
  • uterine size was not larger than 12 weeks
  • there were no signs of severe infection
  • haemodynamically stable
  • in general good health
  • willing to provide contact information
Exclusion Criteria
  • an IUD in place
  • ectopic pregnancy
  • aged below 18 years and had no accompanying adult to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MisoprostolMisoprostol400 mcg of sublingual misoprostol in one dose
Manual vacuum aspiration (MVA)surgery Manual vacuum aspiration (MVA)Standard surgical treatment (MVA)
Primary Outcome Measures
NameTimeMethod
Complete abortion without recourse to surgical interventionfollow up visit 7 days after initial treatment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Adeoyo Maternity Hospital

🇳🇬

Ibadan, Nigeria

University College Hospital, Ibadan

🇳🇬

Ibadan, Nigeria

© Copyright 2025. All Rights Reserved by MedPath